Boston Scientific Corporation
BSX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $414,000 | $865,000 | $928,000 | $1,925,000 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $2,558,000 | $2,228,000 | $1,970,000 | $1,778,000 |
| Inventory | $2,810,000 | $2,484,000 | $1,867,000 | $1,610,000 |
| Other Curr. Assets | $1,138,000 | $937,000 | $995,000 | $1,004,000 |
| Total Curr. Assets | $6,920,000 | $6,514,000 | $5,760,000 | $6,317,000 |
| Property Plant & Equip (Net) | $3,744,000 | $3,298,000 | $2,831,000 | $2,686,000 |
| Goodwill | $17,089,000 | $14,387,000 | $12,920,000 | $11,988,000 |
| Intangibles | $6,684,000 | $6,003,000 | $5,903,000 | $6,120,000 |
| Long-Term Investments | $555,000 | $413,000 | $407,000 | $412,000 |
| Tax Assets | $3,655,000 | $3,841,000 | $3,942,000 | $4,142,000 |
| Other NC Assets | $749,000 | $680,000 | $707,000 | $563,000 |
| Total NC Assets | $32,476,000 | $28,622,000 | $26,710,000 | $25,911,000 |
| Other Assets | -$1,000 | $0 | $0 | $2,000 |
| Total Assets | $39,395,000 | $35,136,000 | $32,470,000 | $32,230,000 |
| Liabilities | – | – | – | – |
| Payables | $960,000 | $942,000 | $862,000 | $794,000 |
| Short-Term Debt | $1,778,000 | $531,000 | $20,000 | $261,000 |
| Tax Payable | $307,000 | $220,000 | $232,000 | $209,000 |
| Deferred Revenue | $306,000 | $266,000 | $220,000 | $208,000 |
| Other Curr. Liab. | $3,048,000 | $2,974,000 | $2,469,000 | $2,802,000 |
| Total Curr. Liab. | $6,399,000 | $4,933,000 | $3,803,000 | $4,274,000 |
| LT Debt | $9,369,000 | $8,961,000 | $9,262,000 | $9,193,000 |
| Deferred Rev, NC | $329,000 | $311,000 | $289,000 | $276,000 |
| Deferred Tax Liab, NC | $155,000 | $134,000 | $144,000 | $310,000 |
| Other NC Liab. | $1,140,000 | $1,267,000 | $1,398,000 | $1,554,000 |
| Total NC Liab. | $10,993,000 | $10,673,000 | $11,093,000 | $11,333,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $527,000 | $395,000 | $352,000 | $395,000 |
| Total Liabilities | $17,392,000 | $15,606,000 | $14,896,000 | $15,607,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $17,000 | $17,000 | $17,000 | $17,000 |
| Retained Earnings | $2,673,000 | $819,000 | -$750,000 | -$1,392,000 |
| AOCI | $275,000 | $49,000 | $269,000 | $263,000 |
| Other Equity | $18,805,000 | $18,397,000 | $18,038,000 | $17,734,000 |
| Total Equity | $21,770,000 | $19,282,000 | $17,574,000 | $16,623,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $233,000 | $248,000 | $0 | $0 |
| Total Liab. & Tot. Equity | $39,395,000 | $35,136,000 | $32,470,000 | $32,230,000 |
| Net Debt | $10,733,000 | $8,627,000 | $8,354,000 | $7,529,000 |